Acne Treatment Manufacturing OTC in the US Industry Market Research Report from IBISWorld Has Been Updated
(PR Web Via Acquire Media NewsEdge) New York, NY (PRWEB) August 03, 2014
The Acne Treatment Manufacturing OTC industry produces nonprescription cleansers, lotions, gels, toners, masks and pads containing acne-fighting ingredients, such as benzoyl peroxide and salicylic acid. According to IBISWorld Industry Analyst Leah Goddard, "The industry benefits from fairly stable demand for these products because acne-prone individuals consider them a necessary expense." However, adolescents comprise the industry's largest market, and high unemployment levels and, thus, low disposable incomes within this shrinking age bracket have caused sales of over-the-counter (OTC) acne treatments to stagnate since the recession. Over the five years to 2014, industry revenue is estimated to marginally decline at an annualized rate of 0.6%, as consumers switched to less expensive products. With the number adolescents decreasing and imports increasing in 2014, industry revenue is forecast to fall 0.7% to $621.3 million.
The industry includes household brand names such as Neutrogena, Clean & Clear, Aveeno, Proactiv and Clearasil, which collectively account for over 70.0% of revenue. In addition to intense competition from leading brand names, market saturation and increasing import penetration has led to some industry consolidation over the past five years. "As the number of competitors has contracted, industry profitability has slightly increased," says Goddard. Moreover, the rising prevalence of adult-onset and persistent acne conditions has resulted in new, targeted products that appeal to consumers with higher disposable incomes; correspondingly, higher prices for these premium products have also contributed to profit growth over the period.
Over the five years to 2019, demand conditions are anticipated to clear up. Declining unemployment and rising disposable incomes will enable consumers to spend more on OTC acne treatments. Furthermore, companies will continue to develop premium treatments with all-natural and organic ingredients to satisfy changing consumer preferences for healthy and environmentally friendly products. However, industry operators will also face greater competition from providers of prescription acne products and laser treatments in coming years. As healthcare reform is implemented, growth in private health insurance coverage will allow individuals to opt for more expensive prescriptions and treatments, limiting demand for OTC products.
For more information, visit IBISWorld's Acne Treatment Manufacturing OTC in the US industry report page.
Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld.
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189.
IBISWorld industry Report Key Topics
This industry manufactures over-the-counter (i.e. nonprescription) acne treatment and medication. Industry products include active ingredients such as benzoyl peroxide, salicylic acid, sulfur, resorcinol or a combination of such ingredients, in addition to a range of inactive ingredients like emollients and surfactants. OTC acne treatments are mostly topical and are manufactured as gels, moisturizers, lotions, creams, soaps and pads.
Key External Drivers
Industry Life Cycle
Products & Markets
Products & Services
Globalization & Trade
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
About IBISWorld Inc.
Recognized as the nation's most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.
Read the full story at http://www.prweb.com/releases/2014/08/prweb12066062.htm
(c) 2014 PRWEB.COM Newswire
[ Back To TMCnet.com's Homepage ]